224 results
Skip to content
Toggle navigation
VuFind
Keyword
-- Title
-- Author
-- Subject
-- Call Number
-- ISBN/ISSN
-- OCLC Number
Title A-Z
Author A-Z
Subject A-Z
Call Number A-Z
Prospector
Find
Advanced
0
items
(Full)
Your Account
Log Out
Login
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Keyword
-- Title
-- Author
-- Subject
-- Call Number
-- ISBN/ISSN
-- OCLC Number
Title A-Z
Author A-Z
Subject A-Z
Call Number A-Z
Prospector
Find
Advanced
Author
Center for Biologics Evaluation and Research (U.S.)
Showing
81
-
100
of
224
for search:
'Center for Biologics Evaluation and Research (U.S.)'
, query time: 0.09s
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
Select Page | with selected:
81
Guidance for industry development and use of risk minimization action plans
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2005
Description: 1 online resource (23 pages)
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
82
Guidance for industry IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2004
Description: 1 online resource (8 pages)
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
83
Guidance for industry clinical lactation studies; study design, data analysis, and recommendations for labeling
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2005
Description: 1 online resource (19 p)
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
84
Guidance for industry information program on clinical trials for serious or life-threatening diseases and conditions
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2002
Description: 1 online resource (9 pages) : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
85
Guidance for industry premarketing risk assessment
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Rresearch, 2005
Description: 1 online resource (i, 26 pages)
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
86
User fees and refunds for premarket approval applications
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health : Center for Biologics Evaluation and Research, 2009
Description: 9 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
87
Guidance for industry clinical pharmacology section of labeling for human prescription drug and biological products : content and format
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) : Center for Biologics Evaluation and Research (CBER), 2009
Description: 11 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
88
Evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on Uniformity of Dosage Units, General Chapter
Published: [U.S. Food and Drug Administration, Center for Biologics Evaluation and Research], 2008
Description: 3 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
89
Guidance for industry contents of a complete submission for the evaluation of proprietary names
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) ; Center for Biologics Evaluation and Research (CBER), 2008
Description: i, 17 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
90
Guidance for industry tropical disease priority review vouchers
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) ; Center for Biologics Evaluation and Research (CBER), 2008
Description: 9 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
91
Guidance for industry and FDA staff interactive review for medical device submissions, 510(k)s, original PMAs, PMA supplements, original BLAs, and BLA supplements
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health : Center for Biologics Evaluation and Research, 2008
Description: 11 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
92
Guidance for industry Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2008
Description: i, 8 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
93
Guidance for industry providing regulatory submissions in electronic format, receipt date
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2007
Description: 6 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
94
Guidance for industry reports on the status of postmarketing study commitments : implementation of section 130 of the Food and Drug Administration Modernization Act of 1997
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2006
Description: 22 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
95
Guidance for industry fast track drug development programs, designation, development and application review
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2006
Description: 21 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
96
Proceedings of the Sixth International Symposium on Pertussis, Jack Masur Auditorium, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, Sept...
Published: Dept. of Health and Human Services, U.S. Public Health Service, Food and Drug Administration ; [Available from the National Technical Information Service], 1990
Description: x, 408 pages : illustrations ; 27 cm.
Located:
Loading...
Call Number:
Loading...
Book
Loading...
Place Hold
Save to List
Saved in:
97
Guidance for industry information request and discipline review letters under the prescription drug user fee act
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research, 2001
Description: 5 pages : digital, PDF file.
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
98
Guidance for industry dosage and administration section of labeling for human prescription drug and biological products, content and format
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2007
Description: 1 online resource (i, 10 pages)
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
99
Guidance for industry SPL standard for content of labeling technical Qs & As
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2009
Description: 1 online resource (9 pages)
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
100
Guidance for industry container closure systems for packaging human drugs and biologics, questions and answers
Published: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2002
Description: 1 online resource (2 pages)
Located:
Loading...
Call Number:
Loading...
Get full text
Electronic
Save to List
Saved in:
Select Page | with selected:
[1]
« Prev
1
2
3
4
5
6
7
8
9
10
11
Next »
[12]
In Prospector
Request items from other Prospector libraries to be delivered to your local library for pickup.
Search Tools:
Get RSS Feed
—
Email this Search
—
Save Search
Related Subjects
Drugs Testing
Drug approval
Blood donors Government policy
Drug development Government policy
Advertising Drugs
Clinical trials Government policy
Clinical trials Reporting
Drugs Labeling
Drug approval Government policy
Drugs Labeling Government policy
Drugs Side effects
Biologicals
Biologicals Labeling
Blood Collection and preservation Government policy
Drugs Testing Government policy
Electronic records Government policy
Medical instruments and apparatus Government policy
Xenografts Government policy
Blood products Government policy
Clinical pharmacology
Drug stability
Electronic filing systems Government policy
User charges
Biological products Safety measures
Biologicals Government policy
Biologicals Safety measures
Blood Examination Government policy
Blood Transfusion Government policy
Blood Transfusion Safety measures
Blood products Evaluation Government policy
×
Loading...